Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suk-Saiyasna is a traditional Thai herbal medicinal formulation historically used for its sedative and sleep-enhancing properties. The remedy contains a mixture of 12 herbal ingredients in specific proportions, including camphor and Azadirachta indica, with cannabis (Cannabis sativa) as a notable component. Its use was discontinued when cannabis became regulated under narcotics laws but has re-emerged following the relaxation of drug control laws in Thailand. Pharmacological studies indicate that Suk-Saiyasna exerts sedative–hypnotic effects by modulating GABAergic neurons via GABAA receptors and activating cannabinoid CB1 receptors. It has demonstrated efficacy in animal models for reducing anxiety-like behavior, increasing sleep duration, and impairing motor coordination at higher doses. In clinical settings, it is primarily prescribed for insomnia but also used for headache, loss of appetite, numbness, and Parkinson’s disease symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Suk-Saiyasna.